Our study using patient plasma supports this hypothesis; in sEVs from patients with more aggressive cancers, only the ST6GAL1 membrane-bound form is detected while both forms are expressed in sEVs from patients with less aggressive cancers. The gene discussed is ST6GAL1; the disease is cancer.